Suppr超能文献

[血管内凝血实验室验证中的副凝血试验。SDPS试验与乙醇系列稀释试验(SD乙醇试验)的比较临床评估]

[Paracoagulation tests in laboratory verification of intravascular coagulation. Comparative clinical evaluation of the SDPS test and of the ethanol test with serial dilution (SD ethanol test)].

作者信息

Doni A, De Simonis S E, Pasquale G

出版信息

Quad Sclavo Diagn. 1975 Mar;11(1):159-75.

PMID:1153697
Abstract

The AA. remark that laboratory diagnosis of intravascular coagulation is a still alive methodological problem. The presence in the flowing blood of certain molecules (fdp) that derive from that alteration of fibrinogen metabolism, that is at the basis of any intravascular coagulation syndrome, can be detected by immunological methods. Paracoagulation tests allow on the contrary to detect fibrin monomers and fibrin degradation products (fdp) that are still clottable (nonenzymatic coagulation). The positivity of these ones constitutes therefore an indirect evidence of the effects of thrombin on fibrinogen and keeps us nearer to the pathogenetic moment which is the real basis of any I.C. syndrome. The AA. make here a parallel between the two principal paracoagulation tests that are S.D.P.S. test according to GUREWICH (1971 [7]) and Ethanol Gelation test according to GODAL (1966 [6]) whose details are given. These two tests were performed in parallel in 589 cases which showed clinical evidence or suspicion of I.C. mostly supported by the further clinical courses of the patients. The two tests are both positive only in 164 cases (27,8%); both non-positive in 109 cases (18,6%); S.D.P.S. test is positive alone in 306 cases (51,9%); Godal's test is positive alone in 10 cases (1,7%). These data, supported by clinical course, allow the AA. to think that S.D.P.S. test is more sensitive than Godal's test. Although the AA. make the hypothesis that S.D.P.S. test may be more sensitive owing to its serial diluitions method that allows it to achieve an optimal ratio between the paracoagulant agent and the molecules which are capable to be clotted (paracoagulated). So they modify Godal's test applying to it too the principle of serial diluitions. The details are given. This new Serial Diluition Ethanol Gelation test is therefore performed in parallel with S.D.P.S. test in 314 cases which showed clinical evidence or suspicion of I.C. mostly supported by further clinical courses of the patients. In this second series of 314 patients the two tests are both positive in 138 cases (43,9%); both non-positive in 33 cases (10,5%); S.D.P.S. test was positive alone in 108 cases (34,3%); S.D.E.G. test was positive alone in 35 cases (11,3%). As we can see in this second series S.D.P.S. test remains more sensitive showing positivities in 246 cases (78,2%) whereas S.D.E.G. test is positive in 173 cases (55,2%). In conclusion the application of serial diluitions also to Ethanol Gelation test increase its sensitivity (from 29,5% to 55,2%), but it does not reach S.D.P.S. test's one. S.D.E.G. test may be really useful in clinics because it gives informations within 10 min but its non-positivity must be supported by the results of S.D.P.S. test which on the contrary gives sure informations only after 24 hours.

摘要

作者指出,血管内凝血的实验室诊断仍是一个活跃的方法学问题。血液中某些源自纤维蛋白原代谢改变的分子(纤维蛋白降解产物)的存在,是任何血管内凝血综合征的基础,可通过免疫学方法检测到。相反,副凝试验可检测仍可凝固的纤维蛋白单体和纤维蛋白降解产物(非酶促凝血)。因此,这些试验的阳性构成了凝血酶对纤维蛋白原作用的间接证据,使我们更接近作为任何血管内凝血综合征真正基础的发病时刻。作者在此对两种主要的副凝试验进行了比较,即根据古雷维奇(1971年[7])的半定量可溶性纤维蛋白单体试验和根据戈达尔(1966年[6])的乙醇胶凝试验,并给出了其详细信息。这两种试验在589例有血管内凝血临床证据或怀疑的病例中同时进行,这些病例大多得到患者进一步临床病程的支持。两种试验均为阳性的仅164例(27.8%);均为阴性的109例(18.6%);半定量可溶性纤维蛋白单体试验单独阳性的306例(51.9%);戈达尔试验单独阳性的10例(1.7%)。这些数据,结合临床病程,使作者认为半定量可溶性纤维蛋白单体试验比戈达尔试验更敏感。尽管作者推测半定量可溶性纤维蛋白单体试验可能因其系列稀释方法而更敏感,该方法使其能够在促凝剂与可凝固(副凝固)分子之间达到最佳比例。因此,他们也将系列稀释原则应用于戈达尔试验并给出了详细信息。这种新的系列稀释乙醇胶凝试验因此与半定量可溶性纤维蛋白单体试验在314例有血管内凝血临床证据或怀疑的病例中同时进行,这些病例大多得到患者进一步临床病程的支持。在这314例患者的第二组中,两种试验均为阳性的138例(43.9%);均为阴性的33例(10.5%);半定量可溶性纤维蛋白单体试验单独阳性的108例(34.3%);系列稀释乙醇胶凝试验单独阳性的35例(11.3%)。如我们在第二组中所见,半定量可溶性纤维蛋白单体试验仍然更敏感,246例(78.2%)呈阳性,而系列稀释乙醇胶凝试验173例(55.2%)呈阳性。总之,将系列稀释应用于乙醇胶凝试验也提高了其敏感性(从29.5%提高到55.2%),但未达到半定量可溶性纤维蛋白单体试验的敏感性。系列稀释乙醇胶凝试验在临床上可能确实有用,因为它在10分钟内即可提供信息,但其阴性结果必须由半定量可溶性纤维蛋白单体试验的结果支持,相反,半定量可溶性纤维蛋白单体试验仅在24小时后才能提供确切信息。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验